- Sofinnova Ventures participated in 8 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $311,000,000 (averaging $38,875,000 per round).
- Apellis Pharma: Venture capital (Series E) ($60M)
- Amplyx Pharmaceuticals, Inc: Venture capital (Series C) ($67M)
- Checkmate Pharmaceuticals: Venture capital (Series B) ($27M)
- Canaan Partners
- New Leaf Venture Partners
- Morgenthaler Ventures
Want to see the complete list?